These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 22047688

  • 1. CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole blood.
    Wang GZ, Haile PA, Daniel T, Belot B, Viet AQ, Goodman KB, Sha D, Dowdell SE, Varga N, Hong X, Chakravorty S, Webb C, Cornejo C, Olzinski A, Bernard R, Evans C, Emmons A, Briand J, Chung CW, Quek R, Lee D, Gough PJ, Sehon CA.
    Bioorg Med Chem Lett; 2011 Dec 15; 21(24):7291-4. PubMed ID: 22047688
    [Abstract] [Full Text] [Related]

  • 2. In vivo activity of an azole series of CCR2 antagonists.
    Smethurst CA, Bevan N, Brooks C, Emmons A, Gough PJ, Mookherjee C, Moores K, Peace S, Philp J, Piercy V, Watson SP, Zippoli M.
    Bioorg Med Chem Lett; 2012 Dec 01; 22(23):7252-5. PubMed ID: 23079519
    [Abstract] [Full Text] [Related]

  • 3. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB, Wang A, Meloni D, Zhang K, Kong L, Feng H, Glenn J, Huang T, Zhang Y, Cao G, Anand R, Zheng C, Xia M, Han Q, Robinson DJ, Storace L, Shao L, Li M, Brodmerkel CM, Covington M, Scherle P, Diamond S, Yeleswaram S, Vaddi K, Newton R, Hollis G, Friedman S, Metcalf B.
    Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7473-8. PubMed ID: 21036044
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M, Hermans B, Goossens J, Moechars D, Gilissen RA, Doyon J, Boeckx S, Coesemans E, Van Lommen G, Van Wauwe JP.
    J Pharmacol Exp Ther; 2008 Oct 15; 327(1):1-9. PubMed ID: 18599682
    [Abstract] [Full Text] [Related]

  • 5. Identification of a sulfonamide series of CCR2 antagonists.
    Peace S, Philp J, Brooks C, Piercy V, Moores K, Smethurst C, Watson S, Gaines S, Zippoli M, Mookherjee C, Ife R.
    Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3961-4. PubMed ID: 20627722
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
    Lim JW, Oh Y, Kim JH, Oak MH, Na Y, Lee JO, Lee SW, Cho H, Park WK, Choi G, Kang J.
    Bioorg Med Chem Lett; 2010 Apr 01; 20(7):2099-102. PubMed ID: 20223662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C, Han N, Arasasingham P, Bo Y, Carmouche M, Chen N, Davis J, Goldberg MH, Hale C, Hsieh FY, Kelly MG, Liu Q, Norman MH, Smith DM, Stec M, Tamayo N, Xi N, Xu S, Bannon AW, Baumgartner JW.
    Bioorg Med Chem Lett; 2005 Mar 15; 15(6):1623-7. PubMed ID: 15745810
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 11. Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
    Koller M, Lingenhoehl K, Schmutz M, Vranesic IT, Kallen J, Auberson YP, Carcache DA, Mattes H, Ofner S, Orain D, Urwyler S.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3358-61. PubMed ID: 21531559
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF, Chi S, Mattia K, Harrington C, Shi Z, Chen S, Jacutin-Porte S, Bennett R, Carson K, Yin W, Kansra V, Gonzalo JA, Coyle A, Jaffee B, Ocain T, Hodge M, LaRosa G, Harriman G.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3141-5. PubMed ID: 17395464
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG, Xiao Z, Shi Q, Cherney RJ, Tebben AJ, De Lucca GV, Santella JB, Mo R, Cvijic ME, Zhao Q, Barrish JC, Carter PH.
    Bioorg Med Chem Lett; 2012 Feb 01; 22(3):1384-7. PubMed ID: 22225639
    [Abstract] [Full Text] [Related]

  • 19. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.
    Sullivan T, Miao Z, Dairaghi DJ, Krasinski A, Wang Y, Zhao BN, Baumgart T, Ertl LS, Pennell A, Seitz L, Powers J, Zhao R, Ungashe S, Wei Z, Boring L, Tsou CL, Charo I, Berahovich RD, Schall TJ, Jaen JC.
    Am J Physiol Renal Physiol; 2013 Nov 01; 305(9):F1288-97. PubMed ID: 23986513
    [Abstract] [Full Text] [Related]

  • 20. The discovery of novel cyclohexylamide CCR2 antagonists.
    Lanter JC, Markotan TP, Zhang X, Subasinghe N, Kang FA, Hou C, Singer M, Opas E, McKenney S, Crysler C, Johnson D, Molloy CJ, Sui Z.
    Bioorg Med Chem Lett; 2011 Dec 15; 21(24):7496-501. PubMed ID: 22061641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.